At first sight, prior reports demonstrating the translational repression of XIAP and BCL-XL through hnRNPA1 binding would suggest that overexpression of this RNP in cancer could be associated with reduced levels of these anti-apoptotic proteins. The gene discussed is BCL2L1; the disease is cancer.